{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:renal-denervation-system",
  "owner": "cardio",
  "kind": "technology",
  "slug": "renal-denervation-system",
  "name": "Renal denervation system",
  "aliases": [
    "Renal denervation catheter",
    "Ablation catheter, renal denervation"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A renal denervation system is the equipment used for renal denervation: an ablation catheter for the renal arteries and the console that powers it. FDA files these catheters under one product code, QYI, in class 3, and defines them as for denervating the renal nerves to lower blood pressure. Two systems received US premarket approval in November 2023: an ultrasound system (P220023, approved 7 November 2023) and a radiofrequency system (P220026, approved 17 November 2023). Their original approval orders, the only ones read (later supplements were not), state the same indication: to reduce blood pressure as an adjunctive treatment in people with hypertension in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure. This page records no study of benefit or harm.",
  "summary_technical": "FDA product code QYI (Ablation Catheter, Renal Denervation), class 3, is an exact match; the openFDA record gives no regulation number. Approval facts are read from the original orders only: P220023 (Paradise Ultrasound Renal Denervation System; Recor Medical, Inc.; APPR 2023-11-07) and P220026 (Symplicity Spyral Multi-Electrode Renal Denervation Catheter with the Symplicity G3 RF Generator; Medtronic, Inc.; APPR 2023-11-17). Later supplements were not read. No MeSH descriptor was found. The procedure has its own page.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-18",
  "last_evidence_check": "2026-11-18",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "fda-product-code",
      "value": "QYI",
      "normalized_value": "QYI",
      "match": "exact",
      "version": "openFDA device classification endpoint, retrieved 2026-11-18",
      "label": "Ablation Catheter, Renal Denervation",
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels",
        "kidneys"
      ],
      "condition-area": [
        "hypertension"
      ]
    }
  },
  "payload": {
    "principle": "A catheter that denervates the renal nerves to lower blood pressure (FDA classification definition).",
    "strengths": [],
    "limitations": [
      "The sources read are one FDA classification record, two original FDA approval orders and a narrative review; they state a definition, indications and the authors' view, and no study result is recorded on this page.",
      "Each approval statement covers its own system only, and later supplements were not read."
    ],
    "required_infrastructure": [
      "The approval order for P220026 names a radiofrequency generator as part of the system."
    ]
  },
  "content_digest": "85744aaf1fd3fc494ec00b5215c40d347a0852ba1777f139857afd2d1b2681a3",
  "review": {
    "content_digest": "85744aaf1fd3fc494ec00b5215c40d347a0852ba1777f139857afd2d1b2681a3",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-qyi-classification",
      "owner": "cardio",
      "subject_entity_id": "cardio:renal-denervation-system",
      "category": "regulatory",
      "statement": "The openFDA device classification for product code QYI names the device type ablation catheter, renal denervation, in class 3, and defines it as for denervating the renal nerves to lower blood pressure.",
      "context": {
        "id": "cardio:ctx-fda-qyi-classification-us",
        "label": "Renal denervation ablation catheters as classified by the US FDA under product code QYI",
        "recipient": "not_applicable",
        "population": "Not applicable: the classification record describes a device type, not a patient group.",
        "care_setting": "Not stated in the classification record",
        "geography": "United States (FDA device classification record)",
        "life_stage_note": "Not applicable",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (regulatory classification)",
        "eligibility": {
          "inclusion": [],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "A regulatory classification, not a finding about benefit or safety. The record gives no regulation number and no device description beyond its one-line definition. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-18",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].product_code",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-classification-qyi-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:56Z",
            "content_hash": "dba9f4a3a4384c8b3d22e8d08150d06b13ae155ef7ca922d31c65d63bd945f85",
            "source_effective_date": "2026-11-09",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-classification-qyi",
            "source_type": "regulator",
            "title": "openFDA device classification, product code QYI (Ablation Catheter, Renal Denervation)",
            "canonical_url": "https://api.fda.gov/device/classification.json?search=product_code:QYI",
            "identifiers": [
              {
                "scheme": "fda-product-code",
                "value": "QYI",
                "normalized_value": "QYI",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA device classification record returned on 2026-11-18 for product code QYI, from a dataset last updated 2026-11-09.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-class-QYI.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].device_name",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-classification-qyi-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:56Z",
            "content_hash": "dba9f4a3a4384c8b3d22e8d08150d06b13ae155ef7ca922d31c65d63bd945f85",
            "source_effective_date": "2026-11-09",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-classification-qyi",
            "source_type": "regulator",
            "title": "openFDA device classification, product code QYI (Ablation Catheter, Renal Denervation)",
            "canonical_url": "https://api.fda.gov/device/classification.json?search=product_code:QYI",
            "identifiers": [
              {
                "scheme": "fda-product-code",
                "value": "QYI",
                "normalized_value": "QYI",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA device classification record returned on 2026-11-18 for product code QYI, from a dataset last updated 2026-11-09.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-class-QYI.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].device_class",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-classification-qyi-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:56Z",
            "content_hash": "dba9f4a3a4384c8b3d22e8d08150d06b13ae155ef7ca922d31c65d63bd945f85",
            "source_effective_date": "2026-11-09",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-classification-qyi",
            "source_type": "regulator",
            "title": "openFDA device classification, product code QYI (Ablation Catheter, Renal Denervation)",
            "canonical_url": "https://api.fda.gov/device/classification.json?search=product_code:QYI",
            "identifiers": [
              {
                "scheme": "fda-product-code",
                "value": "QYI",
                "normalized_value": "QYI",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA device classification record returned on 2026-11-18 for product code QYI, from a dataset last updated 2026-11-09.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-class-QYI.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].definition",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-classification-qyi-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:56Z",
            "content_hash": "dba9f4a3a4384c8b3d22e8d08150d06b13ae155ef7ca922d31c65d63bd945f85",
            "source_effective_date": "2026-11-09",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-classification-qyi",
            "source_type": "regulator",
            "title": "openFDA device classification, product code QYI (Ablation Catheter, Renal Denervation)",
            "canonical_url": "https://api.fda.gov/device/classification.json?search=product_code:QYI",
            "identifiers": [
              {
                "scheme": "fda-product-code",
                "value": "QYI",
                "normalized_value": "QYI",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA device classification record returned on 2026-11-18 for product code QYI, from a dataset last updated 2026-11-09.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-class-QYI.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "54509397d8daf203edacca6430513c981d53fb22760c74373e0878c73551202c",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-qyi-classification.json"
    },
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-renal-denervation-pma-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:renal-denervation-system",
      "category": "descriptive",
      "statement": "Two premarket approvals under product code QYI state an indication for renal denervation systems. The openFDA record of P220023 (Recor Medical, Inc., decision APPR, 7 November 2023) says the Paradise Ultrasound Renal Denervation System is indicated to reduce blood pressure as an adjunctive treatment in hypertension patients in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure. The openFDA record of P220026 (Medtronic, Inc., decision APPR, 17 November 2023) says the Symplicity Spyral Multi-Electrode Renal Denervation Catheter and the Symplicity G3 RF Generator are indicated to reduce blood pressure as an adjunctive treatment in patients with hypertension in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure.",
      "context": {
        "id": "cardio:ctx-fda-renal-denervation-pma-us",
        "label": "Patients with hypertension in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure, as the US approval orders of two renal denervation systems state",
        "recipient": "unknown",
        "population": "Patients with hypertension whose blood pressure is not adequately controlled by lifestyle modifications and antihypertensive medications, as the two approval orders word it. The statements read give no age group.",
        "care_setting": "Renal denervation system used as an adjunctive treatment (the orders' words)",
        "geography": "United States (FDA premarket approval records)",
        "life_stage_note": "Not stated in the statements read",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (regulatory statements)",
        "eligibility": {
          "inclusion": [
            "Hypertension that lifestyle modifications and antihypertensive medications do not adequately control"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim covers the two original approval orders only. Each approval has later supplements in openFDA; they were not read and may change the wording, the devices or the conditions of use. An FDA approval is a decision about a device, not a finding about how well it works. The orders do not use the term resistant hypertension. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-18",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].pma_number",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220023-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:58Z",
            "content_hash": "5fd9d7c59de3fbc4aac32d2f8983ebb03a6e72cdd1e6192b1926f23ac4ceb913",
            "source_effective_date": "2023-11-07",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220023",
            "source_type": "regulator",
            "title": "FDA premarket approval P220023: Paradise Ultrasound Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220023",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220023",
                "normalized_value": "P220023",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220023 (decision date 2023-11-07), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220023 in openFDA were not read.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220023.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].applicant",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220023-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:58Z",
            "content_hash": "5fd9d7c59de3fbc4aac32d2f8983ebb03a6e72cdd1e6192b1926f23ac4ceb913",
            "source_effective_date": "2023-11-07",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220023",
            "source_type": "regulator",
            "title": "FDA premarket approval P220023: Paradise Ultrasound Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220023",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220023",
                "normalized_value": "P220023",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220023 (decision date 2023-11-07), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220023 in openFDA were not read.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220023.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].decision_date",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220023-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:58Z",
            "content_hash": "5fd9d7c59de3fbc4aac32d2f8983ebb03a6e72cdd1e6192b1926f23ac4ceb913",
            "source_effective_date": "2023-11-07",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220023",
            "source_type": "regulator",
            "title": "FDA premarket approval P220023: Paradise Ultrasound Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220023",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220023",
                "normalized_value": "P220023",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220023 (decision date 2023-11-07), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220023 in openFDA were not read.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220023.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].decision_code",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220023-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:58Z",
            "content_hash": "5fd9d7c59de3fbc4aac32d2f8983ebb03a6e72cdd1e6192b1926f23ac4ceb913",
            "source_effective_date": "2023-11-07",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220023",
            "source_type": "regulator",
            "title": "FDA premarket approval P220023: Paradise Ultrasound Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220023",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220023",
                "normalized_value": "P220023",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220023 (decision date 2023-11-07), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220023 in openFDA were not read.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220023.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].product_code",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220023-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:58Z",
            "content_hash": "5fd9d7c59de3fbc4aac32d2f8983ebb03a6e72cdd1e6192b1926f23ac4ceb913",
            "source_effective_date": "2023-11-07",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220023",
            "source_type": "regulator",
            "title": "FDA premarket approval P220023: Paradise Ultrasound Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220023",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220023",
                "normalized_value": "P220023",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220023 (decision date 2023-11-07), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220023 in openFDA were not read.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220023.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].ao_statement, fragment 1 of 2",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220023-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:58Z",
            "content_hash": "5fd9d7c59de3fbc4aac32d2f8983ebb03a6e72cdd1e6192b1926f23ac4ceb913",
            "source_effective_date": "2023-11-07",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220023",
            "source_type": "regulator",
            "title": "FDA premarket approval P220023: Paradise Ultrasound Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220023",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220023",
                "normalized_value": "P220023",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220023 (decision date 2023-11-07), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220023 in openFDA were not read.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220023.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].ao_statement, fragment 2 of 2",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220023-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:58Z",
            "content_hash": "5fd9d7c59de3fbc4aac32d2f8983ebb03a6e72cdd1e6192b1926f23ac4ceb913",
            "source_effective_date": "2023-11-07",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220023",
            "source_type": "regulator",
            "title": "FDA premarket approval P220023: Paradise Ultrasound Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220023",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220023",
                "normalized_value": "P220023",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220023 (decision date 2023-11-07), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220023 in openFDA were not read.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220023.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].pma_number",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220026-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:59Z",
            "content_hash": "d824b3e99fa085f7f599e8a5f9ab199b7fbe589e947c9eeea89082709f3a2629",
            "source_effective_date": "2023-11-17",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220026",
            "source_type": "regulator",
            "title": "FDA premarket approval P220026: Symplicity Spyral Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220026",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220026",
                "normalized_value": "P220026",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220026 (decision date 2023-11-17), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220026 in openFDA were not read. The record's trade name field holds a stray control character, so no quote is taken from it.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220026.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].applicant",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220026-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:59Z",
            "content_hash": "d824b3e99fa085f7f599e8a5f9ab199b7fbe589e947c9eeea89082709f3a2629",
            "source_effective_date": "2023-11-17",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220026",
            "source_type": "regulator",
            "title": "FDA premarket approval P220026: Symplicity Spyral Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220026",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220026",
                "normalized_value": "P220026",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220026 (decision date 2023-11-17), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220026 in openFDA were not read. The record's trade name field holds a stray control character, so no quote is taken from it.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220026.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].decision_date",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220026-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:59Z",
            "content_hash": "d824b3e99fa085f7f599e8a5f9ab199b7fbe589e947c9eeea89082709f3a2629",
            "source_effective_date": "2023-11-17",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220026",
            "source_type": "regulator",
            "title": "FDA premarket approval P220026: Symplicity Spyral Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220026",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220026",
                "normalized_value": "P220026",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220026 (decision date 2023-11-17), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220026 in openFDA were not read. The record's trade name field holds a stray control character, so no quote is taken from it.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220026.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].decision_code",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220026-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:59Z",
            "content_hash": "d824b3e99fa085f7f599e8a5f9ab199b7fbe589e947c9eeea89082709f3a2629",
            "source_effective_date": "2023-11-17",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220026",
            "source_type": "regulator",
            "title": "FDA premarket approval P220026: Symplicity Spyral Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220026",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220026",
                "normalized_value": "P220026",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220026 (decision date 2023-11-17), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220026 in openFDA were not read. The record's trade name field holds a stray control character, so no quote is taken from it.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220026.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].product_code",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220026-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:59Z",
            "content_hash": "d824b3e99fa085f7f599e8a5f9ab199b7fbe589e947c9eeea89082709f3a2629",
            "source_effective_date": "2023-11-17",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220026",
            "source_type": "regulator",
            "title": "FDA premarket approval P220026: Symplicity Spyral Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220026",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220026",
                "normalized_value": "P220026",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220026 (decision date 2023-11-17), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220026 in openFDA were not read. The record's trade name field holds a stray control character, so no quote is taken from it.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220026.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].ao_statement, fragment 1 of 2",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220026-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:59Z",
            "content_hash": "d824b3e99fa085f7f599e8a5f9ab199b7fbe589e947c9eeea89082709f3a2629",
            "source_effective_date": "2023-11-17",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220026",
            "source_type": "regulator",
            "title": "FDA premarket approval P220026: Symplicity Spyral Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220026",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220026",
                "normalized_value": "P220026",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220026 (decision date 2023-11-17), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220026 in openFDA were not read. The record's trade name field holds a stray control character, so no quote is taken from it.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220026.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].ao_statement, fragment 2 of 2",
          "applicability_note": "Quoted at this locator.",
          "snapshot": {
            "id": "cardio:openfda-pma-p220026-2026-11-18",
            "retrieved_at": "2026-11-18T17:25:59Z",
            "content_hash": "d824b3e99fa085f7f599e8a5f9ab199b7fbe589e947c9eeea89082709f3a2629",
            "source_effective_date": "2023-11-17",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-pma-p220026",
            "source_type": "regulator",
            "title": "FDA premarket approval P220026: Symplicity Spyral Renal Denervation System (openFDA record of the original approval)",
            "canonical_url": "https://api.fda.gov/device/pma.json?search=pma_number:P220026",
            "identifiers": [
              {
                "scheme": "fda-pma",
                "value": "P220026",
                "normalized_value": "P220026",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA PMA record of the original approval of P220026 (decision date 2023-11-17), the earliest by decision date, returned on 2026-11-18, dataset last updated 2026-11-09. The later supplements of P220026 in openFDA were not read. The record's trade name field holds a stray control character, so no quote is taken from it.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed at research/snapshots/k32-openfda-pma-P220026.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "67fe003133d90ab9e01dc5aec24fa111e7962f3bb32f51330e48751fbf0a60e9",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-renal-denervation-pma-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "evaluated_for",
        "label": "US approval orders state an indication in hypertension that is not adequately controlled by lifestyle modifications and medications",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-renal-denervation-pma-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Filed under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-devices-and-monitoring",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "uses_technology",
        "label": "Used by",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:renal-denervation",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "technologies/renal-denervation-system/",
  "context_path": "api/v1/context/cardio--renal-denervation-system.md"
}
